Finance

Lists
Why is IMM up 5.31%?
Dive Deeper
IMM:LON
ImmuPharma PLC
GBX 3.42
+5.31%
(+0.17) 1D
Oct 1, 8:55:36 AM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for IMM...
Open
GBX 3.60
High
GBX 3.60
Low
GBX 3.27
Mkt. cap
21.37M
Avg. vol.
1.57M
Volume
354.90K
52-wk high
GBX 14.50
52-wk low
GBX 3.02
EPS
-GBX 0.01
Shares outstanding
623.91M
No. of employees
7
Open
GBX 3.60
High
GBX 3.60
Low
GBX 3.27
Mkt. cap
21.37M
Avg. vol.
1.57M
Volume
354.90K
52-wk high
GBX 14.50
52-wk low
GBX 3.02
EPS
-GBX 0.01
Shares outstanding
623.91M
No. of employees
7
News stories
From web sources and news partners
About ImmuPharma PLC
CEO-
Employees7
Founded1999
Headquarters-
SectorPharmaceutical industry
Websiteimmupharma.co.uk
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
328.10K
328.10K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
298.97K
298.97K
-
-
Operating expense
652.16K
652.16K
-
-
Total operating expenses
652.16K
652.16K
-
-
Operating income
-652.16K
-652.16K
-
-
Other non operating income
184.07K
184.07K
-
-
EBT including unusual items
-111.44K
-111.44K
-
-
EBT excluding unusual items
-111.44K
-111.44K
-
-
Income tax expense
-127.05K
-127.05K
-
-
Effective tax rate
114.00%
114.00%
-
-
Other operating expenses
-1.34K
-1.34K
-
-
Net income
15.61K
15.61K
-
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
367.37K
367.37K
-
-
Interest expense
-9.14K
-9.14K
-
-
Net interest expenses
358.23K
358.23K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-648.78K
-648.78K
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps